Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
10x Genomics (TXG) had Current Liabilities of $153.45M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$642.82M |
|
$-43.54M |
|
$198.94M |
|
$443.88M |
|
$703.81M |
|
$-60.98M |
|
$21.08M |
|
$-39.91M |
|
$-39.91M |
|
$-43.54M |
|
$-43.54M |
|
$-43.54M |
|
$-43.54M |
|
$-60.98M |
|
$-17.17M |
|
124.75M |
|
124.75M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$684.45M |
|
$226.71M |
|
$356.91M |
|
$1.04B |
|
|
Current Liabilities |
$153.45M |
-- |
|
$91.58M |
|
$245.04M |
|
$796.33M |
|
$729.49M |
|
$796.33M |
|
127.69M |
|
| Cash Flow Statement Financials | |
$136.05M |
|
$-13.44M |
|
$6.80M |
|
$344.07M |
|
$473.97M |
|
$129.90M |
|
$109.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
69.05% |
|
-9.49% |
|
-9.49% |
|
-2.67% |
|
-6.21% |
|
-6.77% |
|
$130.12M |
|
-- |
|
-- |
|
-- |
|
0.62 |
|
3.53 |
|
7.79 |
|
46.84 |
|
-5.47% |
|
-5.97% |
|
-4.18% |
|
-5.47% |
|
$6.24 |
|
$1.04 |
|
$1.09 |
|